Jupiter Life Line Hospitals Ltd.

Jupiter Life Line Hospitals Ltd.

243.05
INR
-3.40
(-1.38%)
5.47EPS
51.89P/E
93.16BMarket Cap
Oct 23Next Earn
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
14.83
22.36
27.23
34.74
39.69
45.71
45.35
Basic EPS, GAAP
-0.07
1.56
2.22
5.74
5.89
5.92
5.48
Free Cash Flow per Basic Share
-3.6
1.38
1.22
0.95
-1.86
-7.14
- -
Dividend per Share
- -
- -
0.16
0.18
0.2
0.2
- -
Book Value per Share
7.29
8.95
11.15
35.66
41.37
47.1
- -
Tangible Book Value per Share
7.27
8.93
11.13
35.59
41.23
46.86
- -
Basic Weighted Avg Shares
328
328
328
308
328
328
344
Sales/Revenue/Turnover
4,862
7,331
8,925
10,695
13,013
14,985
15,578
Operating Margin (%)
8.04
16.14
18.35
18.53
18.94
17.18
16.13
Depreciation Expense
307
362
386
424
571
876
929
Net Income, GAAP
-23
511
729
1,766
1,932
1,940
1,881
Effective Tax Rate (%)
247.72
33.7
43.36
9.62
25.67
25.44
24.67
Profit Margin (%)
-0.47
6.97
8.17
16.51
14.85
12.95
12.08
Working Capital
169
572
771
3,040
5,341
4,583
- -
LT Debt
4,212
4,645
4,525
- -
3,841
5,664
- -
Total Equity
2,464
2,884
3,639
11,687
13,563
15,441
- -
Return on Invested Capital (%)
- -
10.64
11.28
17.73
12.39
9.66
- -
Return on Capital (%)
- -
10.36
11.74
19.55
13.38
11.05
- -
Return on Common Equity (%)
- -
19.2
22.12
23.02
15.3
13.38
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
178
- -
LT Borrowings
- -
5,009
- -
LT Finance Leases
- -
655
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
328
328
328
Market Capitalization
91,360
84,003
93,163

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
6,849
- -
Cash, Cash Equivalents & STI
- -
5,405
- -
Accounts Receivable, Net
- -
755
- -
Inventories
- -
383
- -
Total Current Liabilities
- -
2,266
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
178
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
58.85%
13.85%
Free Cash Flow
- -
-40.05%
284.79%
Net Income, GAAP
- -
-426.24%
0.42%
Sales/Revenue/Turnover
- -
25.84%
15.15%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
2,886
3,350
3,328
3,367
13,013
2026
3,530
3,936
3,654
3,878
14,985
2027
4,110
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.36
1.58
1.59
1.38
5.89
2026
1.34
1.75
1.1
1.53
5.92
2027
1.14
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.2
2026
- -
- -
- -
- -
0.2
2027
- -
- -
- -
- -
- -

Company Description

CEO
Ankit Ajay Thakker
Full Time Employees
4,947
Sector
Health services
Industry
Hospital/Nursing management
Address
Jupiter Hospital Thane MA India 400601
IPO Date
Sep 18, 2023
Business
Jupiter Life Line Hospitals Limited operates as a multi-specialty tertiary and quaternary healthcare provider under the Jupiter brand in western India, offering comprehensive medical services including bariatric surgery, breast care, cardiac surgery, cardiology, chest medicine, dental care, dermatology, ear nose and throat care, endocrinology and diabetes management, gastroenterology, general surgery and minimal access surgery, hepatobiliary and pancreatic surgery, hematology and bone marrow transplant, infectious diseases treatment, internal medicine, interventional radiology, mental health services, nephrology, neurology, neurosurgery, nutrition and dietetics, obstetrics and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, robotic surgery, and urology; it also manages a hotel under the Fortune Park Lake City Hotel name in Thane. The company, incorporated in 2002 and headquartered in Mumbai, Maharashtra, commenced operations with its flagship hospital in Thane in 2007, followed by expansions to Pune in 2017 and the acquisition of Vishesh Jupiter Hospital in Indore, Madhya Pradesh, in 2020, with current operational capacity exceeding 1,000 beds across these three locations in Maharashtra and Madhya Pradesh. Recent developments include the commissioning of 22 additional beds in Pune from July 2024 and 78 beds in Indore from January 2025, alongside an 11-bed ICU in Indore; land acquisition in Ghodbundar, Mira Road, Thane district, for a new 300-bed hospital at a cost of Rs 400 crore funded through internal accruals, with construction underway; ongoing development of a 500-bed multi-specialty hospital in Dombivli, Maharashtra, and a tertiary care hospital in Bibvewadi, Pune, as part of a strategy to more than double capacity to 2,500 beds over the next four years.